Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-07 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-06 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0007 |